RxDoctor Payments Data

Jessica Milhomme

Psychiatric/Mental Health · Fort Lauderdale, FLNPI 1760033724

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.9% of the total across 162 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Teva Pharmaceuticals USA, Inc. at 29.2% of the total. 2025 is the largest year on record at $2,432, more than ten times the $23 reported in 2023.

$2,763in general payments, 2019–2025

Across 162 payments — averaging $17.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$806
  • Vanda Pharmaceuticals Inc.$546
  • Neurocrine Biosciences, Inc.$315
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$283
  • Johnson & Johnson$208
  • AbbVie$172
  • plus $433 from 6 others

What the payments were for

  • Food & beverage$2,62395%
  • Education$1405%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,763 in reported general payments places this provider in the 80th percentile of 3,096 psychiatric/mental health providers in Florida.

See all psychiatric/mental health providers in Florida →

Other psychiatric/mental health in Fort Lauderdale

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →